Publisher

U.S. Food and Drug Administration (MedWatch)

Federal regulators. Every headline below is U.S. Food and Drug Administration (MedWatch)'s own and links to the original.

Visit publisher Filter the wire

Source check 1 min ago · Newest item 7 hr ago · 1,441 stories this week · 87 of 90 publishers answering · Browse publishers · RSS feed

Stories from U.S. Food and Drug Administration (MedWatch)

Recall U.S. Food and Drug Administration (MedWatch)

Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination

November 16, 2026— Breckenridge Pharmaceutical, Inc. (Breckenridge) is voluntarily recalling to the consumer level one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination.

Read at U.S. Food and Drug Administration (MedWatch)

Recall U.S. Food and Drug Administration (MedWatch)

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance

FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx

Read at U.S. Food and Drug Administration (MedWatch)

Safety notice U.S. Food and Drug Administration (MedWatch)

Medical Device Correction Update Luna® G3 BPAP System (Model LG3800-30VT)

React Health (3B Medical, Inc.) is providing notice of a voluntary medical device correction (recall) involving specific Luna G3 BPAP System (Model LG3800-30VT) devices due to a data handling issue that may result in incorrect therapy pressure statistical data when the device is operated with Target

Read at U.S. Food and Drug Administration (MedWatch)

Safety notice U.S. Food and Drug Administration (MedWatch)

MedWatch Alert: FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication

FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition: FDA Safety Communication

Read at U.S. Food and Drug Administration (MedWatch)

Recall U.S. Food and Drug Administration (MedWatch)

Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter

FOR IMMEDIATE RELEASE –November 06,2026 – East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) to the hospital/healthcare facility/user level due to the pre

Read at U.S. Food and Drug Administration (MedWatch)

Recall U.S. Food and Drug Administration (MedWatch)

Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues

SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resu

Read at U.S. Food and Drug Administration (MedWatch)

Safety notice U.S. Food and Drug Administration (MedWatch)

Update: Import Alert for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers

The U.S. Food and Drug Administration (FDA) is alerting health care providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.

Read at U.S. Food and Drug Administration (MedWatch)

Safety notice U.S. Food and Drug Administration (MedWatch)

Import Alert for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers

The U.S. Food and Drug Administration (FDA) is alerting health care providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.

Read at U.S. Food and Drug Administration (MedWatch)